http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2467014-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d210f46b1ea250f783263cb21ef76dfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81b5f8f87deb5954572f32e2c8e39a69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate | 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2ecff1cb969031f0cfdf38ae7a2404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37f0cc77846a5d4f4650cbadef1fef1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697dc83738b8432b6ce1508765a4656c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c25c672d6e1ce8a3213ab63852dd6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7e044dddb603ead336a82dc38466757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4a6cc6b8d5a54b70a823830b757558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c8a71dcecaa2a03c6291bd28d21040 |
| publicationDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2467014-C2 |
| titleOfInvention | Polyepitope protein, nucleotide sequence coding polyepitope protein, plasmid with sequence coding polyepitope protein, and preparation of polyepitope protein for induction of immune response on murrain virus |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to a polyepitope vaccine protein applicable for immunisation against murrain virus, nucleic acid coding this protein, recombinant plasmid pA7248-AMV-H-PE for production of said protein in plants and to a vaccine preparation for prevention and protection against infection caused by murrain virus. The polyepitope vaccine protein has the amino acid sequence SEQ ID NO: 1 which contains the amino acid sequence of B-cell epitope of VP4 protein from 21-th to 40-th amino acid starting with N-terminal, the amino acid sequence of B-cell epitope of VP1 protein from 135-th to 160-th amino acid starting with N-terminal, the amino acid sequence of B-cell epitope of VP1 protein from 200-th to 213-th amino acid starting with N-terminal, the amino acid sequence of T-cell epitope of 2C protein from 68-th to 76-th amino acid starting with N-terminal, the amino acid sequence of T-cell epitope of 3D protein from 1-st to 115-th amino acid starting from N-terminal, and the amino acid sequence of T-cell epitope of 3D protein from 421-st to 460-th amino acid of murrain virus serotype O/ Taiwan/99. Nucleic acid coding such protein has the nucleotide sequence SEQ ID NO: 2. Recombinant plasmid pA7248-AMV-H-PE has a physical map presented in dwg. 5. n EFFECT: invention provides creating polyepitope vaccine protein which is applicable for immunisation against murrain virus. n 5 cl, 7 dwg, 2 tbl, 6 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2663004-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2714428-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053286-B2 |
| priorityDate | 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 224.